Life ScienceCompany
Who owns Synpromics?
Synpromics is owned by Asklepios BioPharmaceutical. It was acquired in 2019.
Synpromics is owned by Asklepios BioPharmaceutical. It was acquired in 2019.
Nine Edinburgh Bioquarter,
Edinburgh,
EH16 4UX
United Kingdom,
+44 1316 585 301
www.synpromics.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2019-08-13 | AskBio | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.